These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1100 related articles for article (PubMed ID: 17585167)

  • 1. Clinical-scale expansion of a mixed population of bone-marrow-derived stem and progenitor cells for potential use in bone-tissue regeneration.
    Dennis JE; Esterly K; Awadallah A; Parrish CR; Poynter GM; Goltry KL
    Stem Cells; 2007 Oct; 25(10):2575-82. PubMed ID: 17585167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
    Mauney JR; Volloch V; Kaplan DL
    Biomaterials; 2005 Nov; 26(31):6167-75. PubMed ID: 15913765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix-mediated retention of in vitro osteogenic differentiation potential and in vivo bone-forming capacity by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
    Mauney JR; Kirker-Head C; Abrahamson L; Gronowicz G; Volloch V; Kaplan DL
    J Biomed Mater Res A; 2006 Dec; 79(3):464-75. PubMed ID: 16752403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.
    Heeschen C; Lehmann R; Honold J; Assmus B; Aicher A; Walter DH; Martin H; Zeiher AM; Dimmeler S
    Circulation; 2004 Apr; 109(13):1615-22. PubMed ID: 15037527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.
    Martin-Rendon E; Sweeney D; Lu F; Girdlestone J; Navarrete C; Watt SM
    Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovine bone- and marrow-derived progenitor cells and their potential for scaffold-based bone tissue engineering applications in vitro and in vivo.
    Reichert JC; Woodruff MA; Friis T; Quent VM; Gronthos S; Duda GN; Schütz MA; Hutmacher DW
    J Tissue Eng Regen Med; 2010 Oct; 4(7):565-76. PubMed ID: 20568083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular matrix made by bone marrow cells facilitates expansion of marrow-derived mesenchymal progenitor cells and prevents their differentiation into osteoblasts.
    Chen XD; Dusevich V; Feng JQ; Manolagas SC; Jilka RL
    J Bone Miner Res; 2007 Dec; 22(12):1943-56. PubMed ID: 17680726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway.
    Otsuru S; Tamai K; Yamazaki T; Yoshikawa H; Kaneda Y
    Stem Cells; 2008 Jan; 26(1):223-34. PubMed ID: 17932420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of neurogenic mesenchymal stem cells in human scalp tissue.
    Shih DT; Lee DC; Chen SC; Tsai RY; Huang CT; Tsai CC; Shen EY; Chiu WT
    Stem Cells; 2005 Aug; 23(7):1012-20. PubMed ID: 15941858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulatory effects of statins on bone marrow-derived mesenchymal stem cells. Study of a new therapeutic agent for fracture.
    Sonobe M; Hattori K; Tomita N; Yoshikawa T; Aoki H; Takakura Y; Suguro T
    Biomed Mater Eng; 2005; 15(4):261-7. PubMed ID: 16010034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-culture period of mesenchymal stem cells in osteogenic media influences their in vivo bone forming potential.
    Castano-Izquierdo H; Alvarez-Barreto J; van den Dolder J; Jansen JA; Mikos AG; Sikavitsas VI
    J Biomed Mater Res A; 2007 Jul; 82(1):129-38. PubMed ID: 17269144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A tissue-like construct of human bone marrow MSCs composite scaffold support in vivo ectopic bone formation.
    Ben-David D; Kizhner T; Livne E; Srouji S
    J Tissue Eng Regen Med; 2010 Jan; 4(1):30-7. PubMed ID: 19842114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells.
    Jang YK; Jung DH; Jung MH; Kim DH; Yoo KH; Sung KW; Koo HH; Oh W; Yang YS; Yang SE
    Ann Hematol; 2006 Apr; 85(4):212-25. PubMed ID: 16391912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury.
    Banas A; Teratani T; Yamamoto Y; Tokuhara M; Takeshita F; Osaki M; Kawamata M; Kato T; Okochi H; Ochiya T
    Stem Cells; 2008 Oct; 26(10):2705-12. PubMed ID: 18535155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoting effects of serotonin on hematopoiesis: ex vivo expansion of cord blood CD34+ stem/progenitor cells, proliferation of bone marrow stromal cells, and antiapoptosis.
    Yang M; Li K; Ng PC; Chuen CK; Lau TK; Cheng YS; Liu YS; Li CK; Yuen PM; James AE; Lee SM; Fok TF
    Stem Cells; 2007 Jul; 25(7):1800-6. PubMed ID: 17446559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward the identification of mesenchymal stem cells in bone marrow and peripheral blood for bone regeneration.
    Smiler D; Soltan M; Albitar M
    Implant Dent; 2008 Sep; 17(3):236-47. PubMed ID: 18784524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioreactor expansion of human adult bone marrow-derived mesenchymal stem cells.
    Chen X; Xu H; Wan C; McCaigue M; Li G
    Stem Cells; 2006 Sep; 24(9):2052-9. PubMed ID: 16728560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of multipotential mesenchymal progenitor cells derived from human trabecular bone.
    Tuli R; Tuli S; Nandi S; Wang ML; Alexander PG; Haleem-Smith H; Hozack WJ; Manner PA; Danielson KG; Tuan RS
    Stem Cells; 2003; 21(6):681-93. PubMed ID: 14595128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficiency of Percoll and Ficoll density gradient media in the isolation of marrow derived human mesenchymal stem cells with osteogenic potential.
    Chang Y; Hsieh PH; Chao CC
    Chang Gung Med J; 2009; 32(3):264-75. PubMed ID: 19527605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ablation of proliferating marrow with 5-fluorouracil allows partial purification of mesenchymal stem cells.
    Wang Z; Song J; Taichman RS; Krebsbach PH
    Stem Cells; 2006 Jun; 24(6):1573-82. PubMed ID: 16769762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.